A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...
DISABLED ENTREPRENEUR UK on MSN

Therapies for Multiple Sclerosis

Listen to Post Therapies for Multiple Sclerosis: Exploring Treatments for MS Multiple sclerosis (MS) is a ...
A team from UNIGE and HUG has discovered a subgroup of immune cells particularly involved in the disease, opening the way to ...
The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers, raising hopes for a new therapeutic option for this devastating neurodegenerative disease and ...
It's been known for years that Epstein-Barr virus can trigger multiple sclerosis or drive progression of the degenerative disease, and Swedish researchers think they now understand why. Some people ...
Sanofi announced via press release that its drug frexalimab, directed against the ligand for the costimulatory receptor CD40 (CD40L), met its primary endpoint in patients with relapsing multiple ...